title: Donor-transmitted bacterial infection in heart-lung transplantation.
authors.affiliation: Transplant Unit, Papworth Hospital, Cambridge, England.
authors.forename: F
authors.initials: F
authors.lastname: Ciulli
authors.forename: M
authors.initials: M
authors.lastname: Tamm
authors.forename: C
authors.initials: C
authors.lastname: Dennis
authors.forename: B
authors.initials: B
authors.lastname: Biocina
authors.forename: P
authors.initials: P
authors.lastname: Mullins
authors.forename: F C
authors.initials: FC
authors.lastname: Wells
authors.forename: S R
authors.initials: SR
authors.lastname: Large
authors.forename: J
authors.initials: J
authors.lastname: Wallwork
mesh_terms: D000328:Adult; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy / Q000635:transmission*; D002442:Ceftazidime / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005436:Floxacillin / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology; D016041:Heart-Lung Transplantation / Q000009:adverse effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D005436:Floxacillin; D002442:Ceftazidime